Clinical trial
Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families
NCT00230620 · Imperial College London, Other · Recruiting
Key facts
| NCT number | NCT00230620 |
|---|---|
| Title | Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families |
| Official title | Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families With Pulmonary Arteriovenous Malformations |
| Lead sponsor | Imperial College London, Other |
| Collaborators | British Heart Foundation |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Telangiectasia, Hereditary Hemorrhagic |
| Enrollment | 1,000 |
| Start date | Dec 1, 1998 |
| Primary completion | Apr 1, 2030 |
| Completion | Apr 1, 2030 |
| First posted | Oct 3, 2005 |
| Last update posted | Sep 28, 2023 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: